Connection

Mitzi Nagarkatti to Treatment Outcome

This is a "connection" page, showing publications Mitzi Nagarkatti has written about Treatment Outcome.
Connection Strength

0.063
  1. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood. 2002 Jul 15; 100(2):627-34.
    View in: PubMed
    Score: 0.022
  2. Resveratrol Attenuates Allergic Asthma and Associated Inflammation in the Lungs Through Regulation of miRNA-34a That Targets FoxP3 in Mice. Front Immunol. 2018; 9:2992.
    View in: PubMed
    Score: 0.017
  3. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells. Front Immunol. 2018; 9:1782.
    View in: PubMed
    Score: 0.017
  4. Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. Mol Pharmacol. 2008 Jul; 74(1):20-33.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.